https://www.selleckchem.com/products/c188-9.html
41% and 82.05% at 12 months in the CYC group. The CR rate was significantly higher in the LEF group than in the CYC group both at 6 months (75.61% versus 38.24%, p less then 0.01) and 12 months (77.42% versus 53.33%, p less then 0.05) after adjustment for propensity scores. The incidence of side effects in the LEF group was much lower than that in the CYC group (21.28% versus 44.44%). In conclusion, LEF provided a better treatment response, along with lower reproductive toxicity, compared with CYC in initial-onset TA.Background Clinical
Me gusta
Comentario
Compartir
